Evidence map›Paper›PMID 38532953›Full record

ArticleOpen forum infectious diseases2024

The Enterics for Global Health (EFGH)

Richard Omore, Alex O Awuor, Billy Ogwel, Caleb Okonji, Catherine Sonye, Caren Oreso, Victor Akelo, Manase Amollo, Isaiah Ogudi, Raphael O Anyango and 9 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Quantifying the Cost ofOpen forum infectious diseases · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Richard OmoreCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Alex O AwuorCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Billy OgwelCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Caleb OkonjiCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Catherine SonyeCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Caren OresoCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Victor AkeloDepartment of Clinical Medicine, Liverpool School of Tropical Medicine, Kisumu, Kenya.
Manase AmolloCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Isaiah OgudiCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Raphael O AnyangoCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Marjorie AudiCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Evans ApondiCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Laura RizikiCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Lilian AmbilaCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Nasrin DilrubaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Erick MuokCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Stephen MungaCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
John B OchiengCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Funding

Gates Foundation INV-028721Gates Foundation INV-041730
6 · The paper itself

Abstract

Background: Although Methods: We mobilized our preexisting expertise in shigellosis, vaccinology, and diarrheal disease epidemiology, which we combined with our experience conducting population-based sampling, clinical trials with high (97%-98%) retention rates, and healthcare utilization surveys. We leveraged our established demographic surveillance system (DSS), our network of healthcare centers serving the DSS, and our laboratory facilities with staff experienced in performing microbiologic and molecular diagnostics to identify enteric infections. We joined these resources with an international network of sites with similar capabilities and infrastructure to form a cohesive scientific network, designated Enterics for Global Health (EFGH), with the aim of expanding and updating our knowledge of the epidemiology and adverse consequences of shigellosis and enriching local research and career development priorities. Conclusions:

Identifiers

PMID38532953
PMCPMC10962753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.